bluebird bio, Inc. (BLUE): Price and Financial Metrics
BLUE Price/Volume Stats
| Current price | $8.50 | 52-week high | $38.40 |
| Prev. close | $9.23 | 52-week low | $5.80 |
| Day low | $7.94 | Volume | 900,800 |
| Day high | $9.80 | Avg. volume | 398,189 |
| 50-day MA | $8.59 | Dividend yield | N/A |
| 200-day MA | $16.25 | Market Cap | 82.64M |
BLUE Stock Price Chart Interactive Chart >
bluebird bio, Inc. (BLUE) Company Bio
Bluebird Bio is a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic and rare diseases and T cell-based immunotherapies. The company was founded in 1992 and is based in Cambridge, Massachusetts.
BLUE Price Returns
| 1-mo | 42.67% |
| 3-mo | -9.61% |
| 6-mo | -58.33% |
| 1-year | -69.64% |
| 3-year | -96.18% |
| 5-year | -99.53% |
| YTD | -69.20% |
| 2023 | -80.06% |
| 2022 | -30.73% |
| 2021 | -76.91% |
| 2020 | -50.69% |
| 2019 | -11.54% |
Continue Researching BLUE
Want to do more research on bluebird bio Inc's stock and its price? Try the links below:bluebird bio Inc (BLUE) Stock Price | Nasdaq
bluebird bio Inc (BLUE) Stock Quote, History and News - Yahoo Finance
bluebird bio Inc (BLUE) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...